OR WAIT null SECS
October 23, 2018
Takhzyro (lanadelumab) is the first monoclonal antibody therapy approved for the prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.
October 19, 2018
The recommended drugs include one biosimilar, two orphan medicines, and three extensions of therapeutic indication.
October 18, 2018
The contract development and manufacturing organization released its first serialized products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.
October 17, 2018
Amgen’s biosimilar to AbbVie’s Humira (adalimumab) is the first inflammation biosimilar from Amgen's portfolio to launch in Europe.
October 15, 2018
Clovis Oncology and Lonza celebrated the grand opening of a dedicated production train at Lonza’s Visp, Switzerland site for manufacturing Rubraca (rucaparib).
October 12, 2018
Novartis’ Sandoz has reached a global patent resolution for Hyrimoz (adalimumab), its biosimilar to AbbVie’s Humira (adalimumab).
October 11, 2018
Biotechnology developers should be aware of subtle differences between the way that European and United States patent authorities approach monoclonal antibodies.
Roche has acquired Tusk Therapeutics in a deal worth up to EUR 659 million (US$762 million).
October 10, 2018
A stick-pack laminate packaging film from Amcor uses Pylote’s antimicrobial packaging technology to eliminate the need for preservatives in the liquid pharmaceutical contents.
The company’s three acquisitions over the last 12 months have increased its global presence, expanding its European footprint and bringing new localized services in Asia-Pacific and the west coast of the United States.